Premium
Nektar Therapeutics (0UNL)
LSE
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Actionnaire | Type | Détenues (Réel) | % en Circulation | Valeur Marchande | Date de Reporte |
|---|---|---|---|---|---|
| BVF Partners L.P. | Institution | 2 559 595 | 7,58% | - | 2026-03-31 |
| Two Seas Global (Master) Fund Lp | Institution | 1 959 178 | 5,80% | - | 2026-03-31 |
| Two Seas Capital LP | Institution | 1 959 178 | 5,80% | - | 2026-03-31 |
| Biotechnology Value Fund L.P. | Institution | 1 365 482 | 4,04% | - | 2026-03-31 |
| Vanguard Capital Management, LLC | Institution | 1 197 055 | 3,54% | - | 2026-03-31 |
| Biotechnology Value Fund II, L.P. | Institution | 997 300 | 2,95% | - | 2026-03-31 |
| Two Sigma Investments, LP | Institution | 930 741 | 2,75% | - | 2026-03-31 |
| Prosight Management, LP | Institution | 735 000 | 2,18% | - | 2026-03-31 |
| BlackRock, Inc. | Institution | 692 650 | 2,05% | - | 2026-03-31 |
| Emerald Advisers, LLC | Institution | 650 710 | 1,93% | - | 2026-03-31 |
| Morgan Stanley | Institution | 637 935 | 1,89% | - | 2026-03-31 |
| Armistice Capital LLC | Institution | 578 000 | 1,71% | - | 2026-03-31 |
| Citadel Advisors LLC | Institution | 513 531 | 1,52% | - | 2026-03-31 |
| Sofinnova Investments, Inc. | Institution | 509 546 | 1,51% | - | 2026-03-31 |
| Invesco Ltd. | Institution | 425 341 | 1,26% | - | 2026-03-31 |
| Woodline Partners LP | Institution | 415 335 | 1,23% | - | 2026-03-31 |
| Lord, Abbett & Co. LLC | Institution | 405 080 | 1,20% | - | 2026-03-31 |
| Millennium Management LLC | Institution | 404 277 | 1,20% | - | 2026-03-31 |
| Qube Research & Technologies Ltd | Institution | 390 675 | 1,16% | - | 2026-03-31 |
| Integrated Core Strategies (US) LLC | Institution | 333 576 | 0,99% | - | 2025-09-30 |
| Great Point Partners, LLC | Institution | 316 453 | 0,94% | - | 2026-03-31 |
| Vestal Point Capital, LP | Institution | 285 000 | 0,84% | - | 2026-03-31 |
| 22NW, LP | Institution | 281 115 | 0,83% | - | 2026-03-31 |
| OrbiMed Advisors LLC | Institution | 275 000 | 0,81% | - | 2026-03-31 |
| Gilder Gagnon Howe & Co. LLC | Institution | 271 758 | 0,80% | - | 2026-03-31 |
| Nearwater Capital Markets, Limited | Institution | 261 500 | 0,77% | - | 2026-03-31 |
| Braidwell LP | Institution | 222 701 | 0,66% | - | 2026-03-31 |
| Patient Square Capital, LP | Institution | 210 000 | 0,62% | - | 2026-03-31 |
| Bronte Capital Management Pty Ltd | Institution | 198 256 | 0,59% | - | 2026-03-31 |
| Quinn Opportunity Partners LLC | Institution | 179 247 | 0,53% | - | 2026-03-31 |
| Vanguard Fiduciary Trust Company | Institution | 169 308 | 0,50% | - | 2026-03-31 |
| Dafna Capital Management, LLC | Institution | 165 178 | 0,49% | - | 2026-03-31 |
| ADAR1 Capital Management, LLC | Institution | 161 252 | 0,48% | - | 2026-03-31 |
| Biotechnology Value Trading Fund OS LP | Institution | 153 936 | 0,46% | - | 2026-03-31 |
| Columbia Management Investment Advisers, LLC | Institution | 136 730 | 0,40% | - | 2026-03-31 |
| Deep Track Biotechnology Master Fund, Ltd | Institution | 131 733 | 0,39% | - | 2024-12-31 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
